A Multistate Model Incorporating Relative Survival Extrapolation and Mixed Time Scales for Health Technology Assessment
PharmacoEconomics · 2025
DOI: 10.1007/s40273-024-01457-w ↗Kurz gefasst
Fachartikel in der Zeitschrift PharmacoEconomics, 2025. Verfasst von Enoch Yi-Tung Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, 171 77, Stockholm, Sweden. enoch.yitung.chen@ki.se. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Models, Statistical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cancerfonden, Vetenskapsrådet, Karolinska Institute.
Abstract (Originalsprache)
BACKGROUND: Multistate models have been widely applied in health technology assessment. However, extrapolating survival in a multistate model setting presents challenges in terms of precision and bias. In this article, we develop an individual-level continuous-time multistate model that integrates relative survival extrapolation and mixed time scales. METHODS: We illustrate our proposed model using an illness-death model. We model the transition rates using flexible parametric models. We update the hesim package and the microsimulation package in R to simulate event times from models with mixed time scales. This feature allows us to incorporate relative survival extrapolation in a multistate setting. We compare several multistate settings with different parametric models (standard vs. flexible parametric models), and survival frameworks (all-cause vs. relative survival framework) using a previous clinical trial as an illustrative example. RESULTS: Our proposed approach allows relative survival extrapolation to be carried out in a multistate model. In the example case study, the results agreed better with the observed data than did the commonly applied approach using standard parametric models within an all-cause survival framework. CONCLUSIONS: We introduce a multistate model that uses flexible parametric models and integrates relative survival extrapolation with mixed time scales. It provides an alternative to combine short-term trial data with long-term external data within a multistate model context in health technology assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, 171 77, Stockholm, Sweden. enoch.yitung.chen@ki.se.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, 171 77, Stockholm, Sweden.
ORCID-Profile: Enoch Yi-Tung Chen
Förderung
- Cancerfonden
- Vetenskapsrådet
- Karolinska Institute
Zitieren
APA
Chen, E. Y., Dickman, P. W., & Clements, M. S. (2025). A Multistate Model Incorporating Relative Survival Extrapolation and Mixed Time Scales for Health Technology Assessment. PharmacoEconomics. https://doi.org/10.1007/s40273-024-01457-w
Vancouver
Chen EY, Dickman PW, Clements MS. A Multistate Model Incorporating Relative Survival Extrapolation and Mixed Time Scales for Health Technology Assessment. PharmacoEconomics. 2025. doi:10.1007/s40273-024-01457-w
BibTeX
@article{Chen2025,
author = {Chen, Enoch Yi-Tung and Dickman, Paul W and Clements, Mark S},
title = {A Multistate Model Incorporating Relative Survival Extrapolation and Mixed Time Scales for Health Technology Assessment},
journal = {PharmacoEconomics},
year = {2025},
doi = {10.1007/s40273-024-01457-w}
}
EUVIMED